H.R. 2851 (105th): To prohibit application of a payment limit to a drug or biological under part B of the Medicare Program based on a less costly alternative for courses of treatment begun before the change in payment.


Nov 6, 1997
105th Congress, 1997–1998

Died in a previous Congress

This bill was introduced on November 6, 1997, in a previous session of Congress, but was not enacted.


Barbara Kennelly

Representative for Connecticut's 1st congressional district



Read Text »
Last Updated: Nov 6, 1997
Length: 3 pages

About the bill

Summary (CRS)

Provides that, if the Secretary of Health and Human Services or a carrier reduces a recognized rate for a drug or biological under part B (Supplementary Medical Insurance) of title ... Read more >

The bill’s title was written by its sponsor.


Nov 6, 1997

This is the first step in the legislative process.

This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 2851”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: